FXVeritas

Your research context: Cyprus · CySEC

Back to search results
Scope, limitations and evidence

Regulatory registration and eligibility to open an account are separate checks.

  • XM

    Trading Point Of Financial Instruments Ltd

    CySEC · 120/10

    Licence matched in the regulator register

    Scope, limitations and evidence

    The CySEC investment-firm record matches the entity, licence 120/10 and licence date 5 August 2010, and lists xm.com as an approved domain.

    The card does not explicitly state Active. Register identity is verified separately from an explicit status. Contracting entity, residence acceptance and compensation require separate checks; this does not apply to the Belize entity.

    Scope, limitations and evidence ↗ · 2026-09-30

The comparison or profile below also includes brand-wide information. It may not all apply to the entities above.

XM

Cyprus · CYSEC

Only documents for this country/regulator. Account-opening approval remains a separate check.

Sources

Trading Point of Financial Instruments Limited

Zero: USD7 round trip per USD100,000 traded. EUR/USD minimum spreads: Ultra Low 0.8, Zero 0.

Cyprus entity / EEA scope. Cost disclosure linked from the current legal list; effective date not stated. USD notional, not a flat fee per lot. Holding charges may debit or credit. After at least 90 inactive days, monthly dormant fee USD10, capped at free balance. Minimum spreads retain the 29 September account-page check.

Cyprus Costs and Associated Charges — section 3.1.3, page 3 ↗Cyprus legal documents — current Costs and Charges link ↗ · 2026-09-30Cyprus account overview — EUR/USD minimum spreads ↗ · 2026-09-29

Source checked: 2026-09-30

Lists MT4 and MT5.

Platforms navigation ↗

Source checked: 2026-09-29

Account overview states negative balance protection.

Account types — protection statement ↗

Source checked: 2026-09-29

Compare this broker →
Other scope: brand-wide and other-entity records

These preserved records are not restricted to the selected entity. Do not apply another entity’s terms to the entity above.

XM

  • Active coverage
Brand overview and official site

XM operates through 3 legal entities recorded in the current FXVeritas research file across Belize, Cyprus, and Australia.

Check your entityCompare with other brokers
Visit official website
Official website snapshot
An official website snapshot is not on file for this broker.

Official website snapshot

Sources

Primary-source ledger for this public record. Affiliate and coupon pages are excluded.

  1. Official broker website

    Official broker source · Unverified · Not checked

  2. Trading Point of Financial Instruments Ltd Client Agreement

    Official legal document · official_legal_document · 2026-09-12View source

  3. XM Global Limited Client Agreement

    Official legal document · official_legal_document · 2026-09-12View source

  4. CySEC Trading Point card (blocked this host)

    Regulator · regulator · 2026-09-12

    CySEC CIF Register — Trading Point Of Financial Instruments Ltd — 120/10

    CySEC · regulator_register · 2026-09-30

    View source

  5. XM Affiliation Agreement

    Official legal document · official_legal_document · 2026-09-12View source

  6. XM legal documents index

    Official page · official_product · 2026-09-12View source

  7. XM Global Limited privacy policy

    Official page · official_legal_document · 2026-09-12View source

  8. XM public registration flow

    Official page · official_product · 2026-09-12View source

  9. XM regulation

    Official page · official_product · 2026-09-12View source

Research changes

These are saved research additions, not dates when a regulator changed a licence. Previous source-check and import records remain in the audit archive.

  1. · Source check

    XM · Trading Point of Financial Instruments Limited · costs source check

    Primary source ↗Open research file →

  2. · Source check

    XM · Trading Point of Financial Instruments Limited · platforms source check

    Primary source ↗Open research file →
View full research history →